Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Metyrapone improves endothelial dysfunction in patients with treated depression.

Andrew J M Broadley1, Ania Korszun, Eltigani Abdelaal

  • 1Department of Cardiovascular Medicine, University of Birmingham, Birmingham, England.

Journal of the American College of Cardiology
|July 4, 2006
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sirolimus-Eluting Balloon With Provisional Stenting Versus Systematic Drug-Eluting Stent Implantation to Treat De Novo Coronary Lesions: A Randomized, Open-Label, Noninferiority Trial.

Circulation·2026
Same author

Semaglutide, weight loss, and cardiovascular outcomes in the SELECT trial - Authors' reply.

Lancet (London, England)·2026
Same author

Early Prediction of Heart Failure From Routine Cardiac CT Using Radiomic Phenotyping of Epicardial Fat.

Journal of the American College of Cardiology·2026
Same author

Semaglutide on liver fibrosis and heart outcomes in patients at high risk of liver fibrosis: a prespecified analysis of the SELECT randomized trial.

Nature medicine·2026
Same author

A predictive atlas of disease onset from retinal fundus photographs: a modelling study using data from population-based cohorts.

The Lancet. Digital health·2026
Same author

Ethnicity and Heart Failure Outcomes in England: Role of Specialist Care in a Universal Health System.

Journal of the American College of Cardiology·2026

Metyrapone, a cortisol synthesis inhibitor, improved endothelial dysfunction in patients with depression. This suggests that elevated cortisol levels contribute to vascular abnormalities in depression.

Area of Science:

  • Cardiovascular Medicine
  • Endocrinology
  • Psychiatry

Background:

  • Depression is a risk factor for coronary heart disease, associated with endothelial dysfunction.
  • Endothelial dysfunction in depression may stem from abnormal hypothalamic-pituitary-adrenal (HPA) axis activity and increased cortisol exposure.
  • Cortisol administration is known to induce endothelial dysfunction in healthy individuals.

Purpose of the Study:

  • To investigate the impact of metyrapone, a cortisol synthesis inhibitor, on endothelial dysfunction in patients experiencing treated recurrent major depression.
  • To explore the role of cortisol in mediating endothelial dysfunction associated with depression.

Main Methods:

  • Endothelial function was assessed using flow-mediated dilation (FMD) of the brachial artery.

Related Experiment Videos

  • Thirty patients with depression and 36 matched controls were studied.
  • Patients were randomized to receive either metyrapone or a placebo in a double-blind manner, with FMD remeasured after 6 hours.

    • Main Results:

    • Baseline FMD was significantly impaired in patients with depression compared to controls (p < 0.001).
    • Metyrapone treatment significantly improved FMD in patients (p < 0.001), while the placebo group showed no significant change.
    • Metyrapone effectively reduced plasma cortisol levels, and its positive effect on FMD was statistically significant (p = 0.034).

    Conclusions:

    • Inhibition of cortisol production using metyrapone ameliorates endothelial dysfunction in patients with depression.
    • These findings suggest that cortisol plays a mechanistic role in the endothelial dysfunction observed in depression.
    • Targeting cortisol synthesis may offer a therapeutic strategy for vascular complications in depressive disorders.